home / stock / pbd / pbd news


PBD News and Press, Invesco Global Clean Energy From 12/21/22

Stock Information

Company Name: Invesco Global Clean Energy
Stock Symbol: PBD
Market: NYSE

Menu

PBD PBD Quote PBD Short PBD News PBD Articles PBD Message Board
Get PBD Alerts

News, Short Squeeze, Breakout and More Instantly...

PBD - Energy Outlook 2023: The Growth In Renewables, Batteries, CCS And Hydrogen Infrastructure

Summary We expect to see 58 GW growth in the combined wind and solar market in Europe and 32 GW in the US in 2023. Global commercial CCS capacity that is operational or under development is set to grow by 44% this year to 244 million tonnes per annum. Hydrogen is still in its infanc...

PBD - Investment Strategy Monthly Insights, December 2022

Summary The top two mega themes in terms of global net inflows in 2022 were Climate Change-related themes and Big Data. The largest net outflows came from tech-heavy themes, led by Robotics & Automation. 2023 may bring a return to more normal markets driven by economics rather t...

PBD - Carbon Handprint: It's What Firms Don't Do That Counts

Summary As global warming worries approach critical mass, corporate bond investors expect issuers to be part of the solution. At the epicenter of the climate crisis are greenhouse gases (GHG), which all industries emit in one way or another. Most companies strive to shrink their emi...

PBD - Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce U.S. Food and Drug Administration Acceptance of a Resubmitted Biologics License Application for Pegunigalsidase Alfa for the Proposed Treatment of Fabry Disease

Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce U.S. Food and Drug Administration Acceptance of a Resubmitted Biologics License Application for Pegunigalsidase Alfa for the Proposed Treatment of Fabry Disease PR Newswire CARMIEL, Israel and BOSTON ,...

PBD - Sustainability Matters: The U.S. Prioritizes Climate Change

Summary US President Joe Biden inked the Inflation Reduction Act (IRA) into law on August 16. This legislation will likely be transformative over the long term as it is the largest government-led investment in clean energy in US history. The US goal is to achieve a 50%-52% red...

PBD - Stock Surge To Meet Recession Reality

Summary Surging stocks show markets believe hopes of a soft landing by the Fed to be true. We disagree and stay underweight developed market (DM) stocks. U.S. stocks jumped and bond yields plunged after October CPI rose less than the market expected. But sticky core inflation keep...

PBD - Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Resubmission of Biologics License Application to U.S. Food and Drug Administration for Pegunigalsidase Alfa for the Treatment of Fabry Disease

Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Resubmission of Biologics License Application to U.S. Food and Drug Administration for Pegunigalsidase Alfa for the Treatment of Fabry Disease PR Newswire CARMIEL, Israel and BOSTON , Nov. ...

PBD - Recession-Shy Investors Can Turn To Capital Cycle

Summary The prices of oil, copper, and iron ore are all sharply down from their peaks earlier this year. The transition to green power will, in the medium term, boost demand for hydrocarbons. Even if the global economy were to collapse once again, the capital cycle could allow...

PBD - Quick Thoughts: Midterms And Markets

Summary While a divided US government may look appealing, there are long-term risks amid resulting gridlock. The longest night belonged to the pollsters and pundits, whose predictions for a “red wave” did not come to fruition. Looking at historical relationships ...

PBD - Protalix BioTherapeutics to Report Third Quarter 2022 Financial and Business Results on November 14, 2022

Protalix BioTherapeutics to Report Third Quarter 2022 Financial and Business Results on November 14, 2022 PR Newswire Company to host conference call and webcast at 8:30 a.m. EST CARMIEL, Israel , Nov. 7, 2022 /PRNewswire/ -- Protalix BioThera...

Previous 10 Next 10